GlassScriptPhysician profile
Emma Ester Bendana
NPI 1235303512
$18,126.85
in general payments reported to CMS, 2019-2025
40 companies · $2,660 in 2025
The $2,660 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $325 · 2021: $1,325 · 2022: $2,233 · 2023: $9,995 · 2024: $1,253 · 2025: $2,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,800 · Food and Beverage: $4,728 · Travel and Lodging: $3,261 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,800.00 |
| Food and Beverage | $4,727.69 |
| Travel and Lodging | $3,261.16 |
| Education | $118.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,944.47 | 2019-2025 | Moses 550 D\F\L, Lumenis Pulse 120h, Axonics |
| Axonics, INC. | $1,935.87 | 2021-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $1,416.07 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Siemens Medical Solutions USA, INC. | $764.95 | 2022 | |
| Teleflex LLC | $602.99 | 2021-2025 | Barrigel, Urolift |
| Calyxo, INC. | $476.38 | 2023-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $397.37 | 2019-2023 | Myrbetriq |
| Ge Healthcare | $327.41 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $218.43 | 2022-2025 | Lynparza, Keytruda |
| Pfizer INC. | $200.49 | 2019-2024 | |
| Abbvie INC. | $188.97 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $165.25 | 2023-2025 | Gemtesa, Orgovyx |
| Caldera Medical, INC | $140.80 | 2023-2025 | Desara |
| Progenics Pharmaceuticals, INC. | $134.84 | 2022-2023 | Pylarify |
| Myriad Genetic Laboratories, INC. | $134.02 | 2023 | Myrisk, Bracanalysis Cdx |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Bendana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.